Pretax income is the income that a company earns before paying income taxes. Biohaven's pretax income for the
three
months ended in Mar. 2024 was $-178.94 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was $-518.93 Mil.
Biohaven's pretax margin was %.
Biohaven Pre-Tax Income Historical Data
The historical data trend for Biohaven's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Biohaven's Pre-Tax Income
For the Biotechnology subindustry, Biohaven's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biohaven's Pre-Tax Income Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Biohaven's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Biohaven's Pre-Tax Income falls into.
Biohaven Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Biohaven's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-518.93 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biohaven (NYSE:BHVN) Pre-Tax Income Explanation
Biohaven's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biohaven Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Biohaven's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on discovering and developing therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, immunology, and disease-related biology, including rare disorders. Its neuroscience portfolio includes a broad pipeline of drug candidates modulating distinct nervous system targets, including Kv7, glutamate receptors, myostatin, and TRP channels. Its products target diseases such as migraine, depression, bipolar, and schizophrenia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BHVN has been successfully added to your 